Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer

Oncogene

Volumn 21, Issue 55, 2002, Pages 8506-8509

  Span, Paul N ^a   Manders, Peggy ^a   Heuvel, Joop J ^a   Thomas, Chris M G ^a   Bosch, Remko R ^a   Beex, Louk V A M ^a   Sweep, C G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Breast neoplasms; Extracellular matrix; Gene expression regulation; Oncogene; Quantitative real time RT PCR

Indexed keywords

BIOLOGICAL MARKER; PROTEIN DERIVATIVE; PROTEIN PAI 1; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENCE; FOLLOW UP; HUMAN; HUMAN TISSUE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0037028211     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206040     Document Type: Article

References (18)

1. Behrens P, Rothe M, Wellmann A, Krischler J and Wernert N. (2001). J. Pathol., 194, 43-50.
2. Benz CC. (1998). Endocr-relat. Cancer, 5, 271-282.
3. Cox DR. (1972). J. R. Stat. Soc. B., 34, 187-220.
4. Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M and Nesland JM. (2001). Clin. Cancer Res., 7, 551-557.
5. EORTC (Breast Cancer Cooperative Group). (1980). Eur. J. Cancer, 16, 1513-1516.
6. Gilles C, Polette M, Birembaut P, Brunner N and Thompson EW. (1997). Clin. Exp. Metastasis, 15, 519-526.
7. Himelstein BP, Lee EJ, Sato H, Seiki M and Muschel RJ. (1998). Clin. Exp. Metastasis, 16, 169-177.
8. Iwasaka C, Tanaka K, Abe M and Sato Y. (1996). J. Cell. Physiol., 169, 522-531.
9. Janicke F, Prechtl A, Thomssen C, Harbeck N, Meisner C, Untch M, Sweep CGJ, Selbmann HK, Graeff H, Schmitt M and The German N0 Study Group. (2001). J. Natl. Cancer Inst., 93, 913-920.
10. Kaplan EL and Meier P. (1958). J. Am. Statis. Assoc., 53, 457-481.
11. Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Ferno M, Eppenberger-Castori S, Sweep CGJ, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brunner N, Duggan C, Lisboa BW, Bendahl PO, Quillien V, Daver A, Ricolleau G, Meijer-Van Gelder ME, Manders P, Fiets WE, Blankenstein MA, Broet P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LVAM, Klijn JG, O'Higgins N, Eppenberger U, Janicke F, Schmitt M and Foekens JA. (2002). J. Natl. Cancer Inst., 94, 116-128.
12. Nunn MF, Seeburg PH, Moscovici C and Duesberg PH. (1983). Nature, 306, 391-395.
13. Oda N, Abe M and Sato Y. (1999). J. Cell. Physiol., 178, 121-132.
14. Sementchenko VI and Watson DK. (2000). Oncogene, 19, 6533-6548.
15. Trojanowska M. (2000). Oncogene, 19, 6464-6471.
16. Wasylyk B, Hahn SL and Giovane A. (1993). Eur. J. Biochem., 211, 7-18.
17. Watabe T, Yoshida K, Shindoh M, Kaya M, Fujikawa K, Sato H, Seiki M, Ishii S and Fujinaga K. (1998). Int. J. Cancer, 77, 128-137.
18. Watson D, McWilliams-Smith MJ, Nunn MF, Duesberg PH, O'Brien SJ and Papas TS. (1985). Proc. Natl. Acad. Sci. USA, 82, 7294-7298.